Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Building a predictive breast cancer risk model.

Constance M Johnson1, Joe Ensor, Kristine Broglio

  • 1The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|August 13, 2008
PubMed
Summary

A new online tool assesses breast cancer risk using established epidemiological, clinical, and genetic factors. This development aims to improve personalized risk evaluation for women.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Journal of the National Cancer Institute·2026
Same author

Lifestyle Program for Breast Cancer Improves Body Composition, Fitness, and Patient-Reported Outcomes: A Randomized Clinical Trial.

Cancers·2026
Same author

Biomarker-Based Eligibility for Lung Cancer Screening: Validation of the Protein-Based INTEGRAL-Risk Model.

JAMA·2026
Same author

Erratum: Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

JCO precision oncology·2026
Same author

The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer.

Breast cancer research : BCR·2026
Same author

Time-resolved EEG decoding reveals altered neural dynamics of affective semantic evaluation in depression and suicidality.

Communications biology·2026

Area of Science:

  • Oncology
  • Epidemiology
  • Genetics
  • Medical Informatics

Background:

  • Breast cancer remains a significant global health concern.
  • Accurate risk assessment is crucial for early detection and prevention strategies.
  • Existing risk models may not fully integrate diverse risk factors.

Purpose of the Study:

  • To develop and present a novel breast cancer risk assessment tool.
  • To create a web-based platform for accessibility and widespread use.
  • To integrate multiple categories of risk factors for comprehensive evaluation.

Main Methods:

  • Leveraging established epidemiological data.
  • Incorporating recognized clinical indicators.
  • Utilizing known genetic predispositions.

Related Experiment Videos

  • Developing a World-Wide-Web based application.

    • Main Results:

    • A functional breast cancer risk assessment tool has been developed.
    • The tool synthesizes epidemiological, clinical, and genetic data.
    • The platform is accessible via the World-Wide-Web.

    Conclusions:

    • The developed tool offers a comprehensive approach to breast cancer risk assessment.
    • Web-based accessibility enhances potential for broad clinical and public health application.
    • This tool can aid in personalized risk stratification and inform preventative measures.